PEGCETACOPLAN for Macular degeneration: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where PEGCETACOPLAN was used for Macular degeneration.
Most Reported Side Effects for PEGCETACOPLAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 135 | 9.9% | 1 | 44 |
| Visual impairment | 125 | 9.1% | 0 | 4 |
| Haemoglobin decreased | 106 | 7.7% | 1 | 51 |
| Haemolysis | 100 | 7.3% | 1 | 57 |
| Off label use | 97 | 7.1% | 9 | 35 |
| Vitreous floaters | 78 | 5.7% | 0 | 4 |
| Breakthrough haemolysis | 67 | 4.9% | 1 | 18 |
| Headache | 66 | 4.8% | 2 | 25 |
| Product dose omission issue | 59 | 4.3% | 2 | 26 |
| Uveitis | 59 | 4.3% | 0 | 0 |
| Covid-19 | 56 | 4.1% | 1 | 21 |
| Vitritis | 55 | 4.0% | 0 | 5 |
| Choroidal neovascularisation | 52 | 3.8% | 1 | 2 |
| Eye inflammation | 52 | 3.8% | 0 | 2 |
| Drug ineffective | 49 | 3.6% | 8 | 15 |
Other Indications for PEGCETACOPLAN
Paroxysmal nocturnal haemoglobinuria (559)
Product used for unknown indication (352)
Dry age-related macular degeneration (326)
C3 glomerulopathy (27)
Age-related macular degeneration (23)
Neovascular age-related macular degeneration (13)
Other Drugs Used for Macular degeneration
AFLIBERCEPT (945)
RANIBIZUMAB (637)
BEVACIZUMAB (442)
MINERALS\VITAMINS (129)
FLUOCINOLONE ACETONIDE (117)
FARICIMAB\FARICIMAB-SVOA (111)
FARICIMAB-SVOA (67)
BROLUCIZUMAB-DBLL (51)
LUCENTIS (51)
DEXAMETHASONE (43)